Zinc in PDB 5sfu: Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide, PDB code: 5sfu
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.55 /
2.40
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.029,
135.029,
234.652,
90,
90,
120
|
R / Rfree (%)
|
19.2 /
25.6
|
Other elements in 5sfu:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide
(pdb code 5sfu). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide, PDB code: 5sfu:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sfu
Go back to
Zinc Binding Sites List in 5sfu
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:41.2
occ:1.00
|
NE2
|
A:HIS563
|
2.1
|
30.1
|
1.0
|
O
|
A:HOH924
|
2.1
|
29.9
|
1.0
|
OD2
|
A:ASP564
|
2.1
|
35.6
|
1.0
|
OD1
|
A:ASP674
|
2.1
|
48.8
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
35.3
|
1.0
|
O
|
A:HOH948
|
2.6
|
42.4
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
31.8
|
1.0
|
CG
|
A:ASP674
|
3.0
|
38.5
|
1.0
|
CE1
|
A:HIS563
|
3.1
|
30.6
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
34.5
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
35.9
|
1.0
|
CG
|
A:ASP564
|
3.2
|
33.0
|
1.0
|
OD2
|
A:ASP674
|
3.3
|
42.5
|
1.0
|
OD1
|
A:ASP564
|
3.8
|
36.4
|
1.0
|
MG
|
A:MG802
|
3.8
|
31.1
|
1.0
|
O
|
A:HOH918
|
4.1
|
46.7
|
1.0
|
CG
|
A:HIS563
|
4.1
|
30.6
|
1.0
|
ND1
|
A:HIS563
|
4.1
|
30.1
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
34.9
|
1.0
|
CD2
|
A:HIS525
|
4.2
|
35.1
|
1.0
|
CG
|
A:HIS529
|
4.2
|
32.0
|
1.0
|
O
|
A:HOH959
|
4.3
|
32.1
|
1.0
|
CB
|
A:ASP564
|
4.3
|
31.3
|
1.0
|
CB
|
A:ASP674
|
4.4
|
40.0
|
1.0
|
O
|
A:HOH906
|
4.5
|
31.6
|
1.0
|
CG2
|
A:VAL533
|
4.6
|
30.2
|
1.0
|
NE2
|
A:HIS525
|
4.6
|
33.3
|
1.0
|
O
|
A:ASP674
|
4.7
|
40.8
|
1.0
|
CA
|
A:ASP674
|
4.8
|
35.5
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sfu
Go back to
Zinc Binding Sites List in 5sfu
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:37.5
occ:1.00
|
NE2
|
B:HIS563
|
2.1
|
31.0
|
1.0
|
OD2
|
B:ASP564
|
2.1
|
32.7
|
1.0
|
OD1
|
B:ASP674
|
2.1
|
40.5
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
33.8
|
1.0
|
O
|
B:HOH919
|
2.3
|
19.4
|
1.0
|
CG
|
B:ASP674
|
3.0
|
35.4
|
1.0
|
CD2
|
B:HIS563
|
3.1
|
32.4
|
1.0
|
CD2
|
B:HIS529
|
3.1
|
32.5
|
1.0
|
CG
|
B:ASP564
|
3.1
|
32.4
|
1.0
|
CE1
|
B:HIS563
|
3.1
|
33.8
|
1.0
|
OD2
|
B:ASP674
|
3.2
|
38.9
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
36.0
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
33.8
|
1.0
|
MG
|
B:MG802
|
3.9
|
28.5
|
1.0
|
O
|
B:HOH940
|
3.9
|
31.2
|
1.0
|
CD2
|
B:HIS525
|
4.1
|
38.7
|
1.0
|
CG
|
B:HIS563
|
4.2
|
31.4
|
1.0
|
ND1
|
B:HIS563
|
4.2
|
31.2
|
1.0
|
CG
|
B:HIS529
|
4.3
|
34.1
|
1.0
|
CB
|
B:ASP564
|
4.3
|
32.5
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
33.0
|
1.0
|
O
|
B:HOH943
|
4.3
|
46.2
|
1.0
|
CB
|
B:ASP674
|
4.3
|
35.5
|
1.0
|
NE2
|
B:HIS525
|
4.5
|
36.2
|
1.0
|
O
|
B:HOH915
|
4.6
|
30.6
|
1.0
|
O
|
B:ASP674
|
4.7
|
37.5
|
1.0
|
CA
|
B:ASP674
|
4.8
|
33.7
|
1.0
|
CG2
|
B:VAL533
|
4.9
|
30.6
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sfu
Go back to
Zinc Binding Sites List in 5sfu
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:39.1
occ:1.00
|
OD2
|
C:ASP564
|
2.0
|
41.6
|
1.0
|
NE2
|
C:HIS529
|
2.1
|
35.6
|
1.0
|
O
|
C:HOH915
|
2.1
|
26.4
|
1.0
|
NE2
|
C:HIS563
|
2.1
|
31.5
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
38.9
|
1.0
|
CE1
|
C:HIS529
|
3.0
|
30.9
|
1.0
|
CG
|
C:ASP674
|
3.0
|
35.2
|
1.0
|
CG
|
C:ASP564
|
3.1
|
32.9
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
33.8
|
1.0
|
CE1
|
C:HIS563
|
3.1
|
32.2
|
1.0
|
CD2
|
C:HIS563
|
3.2
|
30.9
|
1.0
|
OD2
|
C:ASP674
|
3.2
|
34.1
|
1.0
|
OD1
|
C:ASP564
|
3.6
|
37.0
|
1.0
|
MG
|
C:MG802
|
3.9
|
31.8
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
45.2
|
1.0
|
ND1
|
C:HIS529
|
4.1
|
30.0
|
1.0
|
CG
|
C:HIS529
|
4.2
|
30.3
|
1.0
|
ND1
|
C:HIS563
|
4.2
|
26.6
|
1.0
|
CB
|
C:ASP564
|
4.2
|
32.2
|
1.0
|
CG
|
C:HIS563
|
4.3
|
30.5
|
1.0
|
O
|
C:HOH936
|
4.4
|
45.3
|
1.0
|
O
|
C:HOH964
|
4.4
|
32.3
|
1.0
|
CB
|
C:ASP674
|
4.4
|
36.7
|
1.0
|
NE2
|
C:HIS525
|
4.5
|
43.6
|
1.0
|
O
|
C:HOH934
|
4.5
|
33.4
|
1.0
|
O
|
C:ASP674
|
4.8
|
33.6
|
1.0
|
CA
|
C:ASP674
|
4.8
|
36.3
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
33.2
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sfu
Go back to
Zinc Binding Sites List in 5sfu
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 6- Cyclopropyl-3-(Pyrimidin-5-Ylamino)-N-[4-(Pyrrolidine-1-Carbonyl) Pyridin-3-Yl]Pyridine-2-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:66.1
occ:1.00
|
NE2
|
D:HIS563
|
2.1
|
49.1
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
62.8
|
1.0
|
O
|
D:HOH913
|
2.2
|
64.0
|
1.0
|
OD1
|
D:ASP674
|
2.3
|
58.1
|
1.0
|
OD2
|
D:ASP564
|
2.3
|
65.7
|
1.0
|
O
|
D:HOH915
|
2.4
|
37.3
|
1.0
|
CD2
|
D:HIS563
|
3.0
|
50.9
|
1.0
|
CD2
|
D:HIS529
|
3.1
|
65.2
|
1.0
|
CE1
|
D:HIS563
|
3.2
|
51.5
|
1.0
|
CE1
|
D:HIS529
|
3.3
|
64.8
|
1.0
|
CG
|
D:ASP564
|
3.3
|
57.9
|
1.0
|
CG
|
D:ASP674
|
3.4
|
59.2
|
1.0
|
OD1
|
D:ASP564
|
3.9
|
56.4
|
1.0
|
O
|
D:HOH911
|
4.0
|
48.3
|
1.0
|
OD2
|
D:ASP674
|
4.0
|
67.0
|
1.0
|
MG
|
D:MG802
|
4.1
|
52.6
|
1.0
|
CD2
|
D:HIS525
|
4.2
|
70.2
|
1.0
|
CG
|
D:HIS563
|
4.2
|
52.1
|
1.0
|
CB
|
D:ASP564
|
4.2
|
59.8
|
1.0
|
ND1
|
D:HIS563
|
4.3
|
53.7
|
1.0
|
CG
|
D:HIS529
|
4.3
|
62.9
|
1.0
|
ND1
|
D:HIS529
|
4.3
|
66.2
|
1.0
|
O
|
D:HOH903
|
4.5
|
47.1
|
1.0
|
CB
|
D:ASP674
|
4.5
|
61.6
|
1.0
|
O
|
D:ASP674
|
4.6
|
69.6
|
1.0
|
NE2
|
D:HIS525
|
4.7
|
70.4
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
60.3
|
1.0
|
CA
|
D:ASP674
|
4.8
|
61.3
|
1.0
|
O
|
D:HOH912
|
4.9
|
41.7
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 05:04:36 2024
|